Home Data Calendar Blog

ARWR

Tables

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31
Common Stock Value 0.200.200.200.200.200.200.200.200.190.190.190.190.190.190.190.180.180.180.180.170.170.170.170.170.160.150.150.150.150.150.150.150.150.150.140.130.120.120.110.110.110.110.110.110.090.07NANA
Weighted Average Number Of Diluted Shares Outstanding NA105.75107.93104.53NA104.10103.87102.76NA101.84101.6597.09NA98.8898.0895.59NA87.6384.0874.83NANANANANANANANANANANANANANANANANANANANANA11.2410.66NANA71.837.89NA
Weighted Average Number Of Shares Outstanding Basic NA105.75105.55104.53NA104.10103.87102.76NA101.84101.6597.09NA94.9494.1691.09NA87.6384.0874.83NANANANANANANANANANANANANANANANANANANANANA11.2410.66NANA71.837.18NA
Earnings Per Share Basic -0.81-0.680.42-0.60-0.61-0.29-0.26-0.20-0.48-0.13-0.20-0.030.120.210.250.13-0.12-0.18-0.18-0.18NANANANANANANANANANANANANANANANANANA-0.41-0.33-0.42-0.71-0.50-0.25-0.39-0.030.40NA
Earnings Per Share Diluted -0.81-0.680.41-0.60-0.61-0.29-0.26-0.20-0.48-0.13-0.20-0.030.120.210.240.13-0.12-0.18-0.18-0.18NANANANANANANANANANANANANANANANANANANANANA-0.71-0.50NA-0.36-0.030.37NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31
Revenue From Contract With Customer Excluding Assessed Tax 31.5732.41151.8127.4438.2845.8932.8121.307.6327.3823.5329.4543.2942.7048.1534.6611.260.730.653.518.719.348.994.370.030.040.040.040.040.120.040.170.040.040.040.040.040.040.040.160.040.050.030.020.000.000.000.30
Revenues 31.5732.41151.8127.4438.2845.8932.8121.307.6327.3823.5329.4543.2942.7048.1534.6611.260.730.653.518.719.348.994.370.030.040.040.040.040.120.040.170.040.040.040.040.040.040.040.160.040.050.030.020.000.000.000.30
Operating Expenses 115.41105.32110.2590.76103.1777.7661.0445.3657.7543.3245.7734.3133.6524.1026.1423.7122.4216.6515.6817.3218.9615.0615.1219.2721.8319.3821.3119.3925.2716.1229.6825.2922.4012.7411.267.058.046.435.434.975.426.854.904.062.911.771.813.63
Research And Development Expense Excluding Acquired In Process Cost 83.3872.1875.9865.7765.7759.3344.7036.5543.4832.5729.4423.3723.3919.2920.8017.5715.9912.0512.008.438.286.916.989.5311.679.4210.0210.3410.397.4911.6417.74NANANANANANANANANANANANANANANANA
General And Administrative Expense 32.0333.1434.2725.0037.4018.4316.358.8014.2710.7516.3310.9310.274.815.346.146.434.593.681.671.511.851.621.851.902.283.821.952.321.831.702.092.031.581.350.910.890.900.780.921.103.140.931.281.720.640.820.63
Operating Income Loss -83.83-72.9141.55-63.32-64.88-31.87-28.23-24.05-50.12-15.95-22.24-4.859.6418.6022.0110.95-11.17-15.92-15.03-13.81-10.25-5.71-6.13-14.90-21.80-19.34-21.26-19.34-25.23-15.99-29.63-25.12-22.35-12.70-11.21-7.01-8.00-6.39-5.39-4.81-5.38-6.80-4.87-4.04-2.91-1.77-1.81-3.34
Interest Income Expense Nonoperating Net 1.581.241.051.161.151.281.522.172.272.332.402.182.241.741.891.090.400.310.170.160.150.130.110.030.050.030.080.100.130.160.200.240.260.230.120.04NANANANANANANANANANANANA
Profit Loss NANA44.37-62.87-63.37-29.92-26.82-20.73-48.43-13.61-19.84-2.6711.7020.3423.9012.04-10.76-15.61-14.88-13.20-10.73-5.52-6.04-12.09-22.22-19.42-20.82-19.26-24.75-15.94-28.68-22.58-22.43-11.63-13.98-10.69-13.81-6.18-6.94-4.78-5.60-8.24-5.58-2.69-2.95-2.012.70-1.23
Net Income Loss -85.51-72.0544.37-62.87-63.37-29.92-26.82-20.73-48.43-13.61-19.84-2.6711.7020.3423.9012.04-10.76-15.61-14.88-13.20-10.73-5.52-6.04-12.09-22.22-19.42-20.82-19.26-24.75-15.94-28.68-22.58-22.43-11.63-13.94-10.63-13.69-6.08-6.76-4.61-5.31-7.99-5.34-2.49-2.78-1.822.91-1.44
Comprehensive Income Net Of Tax NA-72.0844.37-62.91-63.51-29.96-26.91-20.55-48.24-13.16-20.27-2.4811.4220.3023.8712.02-10.78-15.63-14.88-13.21-10.68-5.51-5.89-12.28-22.18-19.51-20.67-19.22-24.81-15.94-28.75-22.58-22.43-11.63-13.94NANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31
Assets 691.94751.78703.58638.54710.15734.93756.79499.25522.50555.73561.08587.60349.85336.83333.94340.95111.61112.90127.0088.22104.02115.08126.87144.26128.1885.5394.61111.38132.27145.19162.38162.14182.82196.62202.6492.6937.3341.4912.4215.2316.5316.4920.0823.0615.8913.29NANA
Liabilities And Stockholders Equity 691.94751.78703.58638.54710.15734.93756.79499.25522.50555.73561.08587.60349.85336.83333.94340.95111.61112.90127.0088.22104.02115.08126.87144.26128.1885.5394.61111.38132.27145.19162.38162.14182.82196.62202.6492.6937.3341.4912.4215.2316.5316.4920.0823.0615.8913.29NANA
Stockholders Equity 398.52453.93NANA408.82NANANA461.78493.14494.12500.08244.59226.23201.20172.0695.80102.31114.2770.7581.4290.1093.8997.7695.5859.9874.4892.92110.18131.30144.75146.26166.54186.36191.4082.7327.5034.965.318.9710.019.3712.2416.1712.7910.63NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31
Assets Current 405.30432.39417.63338.28384.60525.96586.76323.72322.37315.23314.47507.61265.25244.54234.97248.9578.7761.8792.6653.1167.9077.9089.69106.2390.5049.6066.1482.28102.87114.69120.15132.16154.80163.42161.9276.4128.8434.413.746.066.575.908.829.179.867.05NANA
Cash And Cash Equivalents At Carrying Value NA139.4486.4191.59184.43325.98372.38139.92143.58219.32256.65461.03221.80188.33161.64189.7730.1328.0069.8111.5324.8438.3861.72102.1185.3743.6250.3062.1781.2187.2596.45103.99132.51138.35142.8559.7119.1129.033.312.933.382.283.606.777.514.324.795.47
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 108.00NANANA184.43NANANA143.58NANANA221.80189.33NANA30.1328.00NANA24.84NANANANANANANANANANANANANANANANANANANANANANANANANANANA
Marketable Securities Current NA0.00122.58126.01126.73126.41125.7986.0185.02NANANANANANANANANANANANANANANANANANANANANANA23.5321.6523.8317.8015.919.034.06NA0.060.110.110.080.070.63NANANA
Accounts Receivable Net Current 1.410.241.320.1510.260.670.959.000.8521.691.271.350.662.0413.423.170.330.010.020.150.070.940.580.060.07NANANANANANANANANANA0.070.07NANA0.120.01NANANANANANANA
Other Assets Current 20.208.897.802.792.191.701.842.321.782.412.541.532.561.491.590.480.640.280.361.601.360.901.753.503.771.510.911.900.820.650.330.060.050.540.63NA0.09NANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31
Property Plant And Equipment Gross 141.85101.2482.0777.3271.5468.5858.6251.4647.1945.3543.2239.3435.3028.5024.2224.4523.7423.3023.1222.7422.6022.4921.3421.4419.9018.8610.5710.479.999.158.878.578.067.616.966.466.596.496.336.376.466.797.827.650.370.37NANA
Furniture And Fixtures Gross 2.18NANANA1.661.161.020.660.660.660.640.630.640.590.590.600.600.600.600.600.600.600.550.600.440.450.420.410.400.370.370.370.330.330.320.320.320.320.320.320.320.510.500.500.290.29NANA
Leasehold Improvements Gross 42.0242.0242.0241.9841.8742.9333.1126.6825.2424.8824.1923.3221.5815.2012.4712.2712.2412.2112.2112.2112.2112.1612.0012.0011.8910.993.183.173.123.123.123.123.052.962.752.752.752.752.752.752.75NANANANANANANA
Construction In Progress Gross 56.3722.346.412.150.34NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 31.5529.3427.1825.0122.8620.7919.2217.7316.3014.9613.8512.9112.0811.4210.8510.539.819.278.537.807.096.365.625.274.516.586.195.815.465.044.744.454.193.933.673.283.082.702.321.941.571.421.070.720.340.34NANA
Amortization Of Intangible Assets 0.400.400.400.400.400.400.400.400.430.430.430.430.430.430.430.430.430.430.430.430.430.430.430.430.430.430.430.440.440.440.160.010.010.010.010.010.010.070.070.07NANANA0.070.060.06NA0.06
Property Plant And Equipment Net 110.3071.9054.8952.3048.6747.7939.4033.7330.8830.3929.3626.4323.2117.0713.3813.9213.9414.0314.5814.9315.5116.1315.7116.1715.3912.274.384.674.534.114.134.123.873.673.293.193.513.794.014.434.905.376.756.930.030.03NANA
Finite Lived Intangible Assets Net 11.9612.3912.8113.2413.6614.0914.5114.9415.3615.7916.2116.6417.0617.4917.9118.3418.7619.1919.6120.0420.4620.8921.3121.7422.1622.5923.0223.4423.8824.3224.760.050.070.080.100.110.120.141.521.591.67NANANA1.73NANANA
Other Assets Noncurrent 0.220.280.280.270.270.270.270.270.270.270.140.140.140.170.140.140.140.140.140.140.140.150.150.120.120.120.120.050.05NANANANANANA13.094.973.284.674.745.065.224.526.966.006.21NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31
Liabilities Current 138.85128.21138.86137.03146.54195.43167.1925.0940.6842.7853.3373.7097.0787.09101.81134.6112.367.139.1213.7218.7020.3227.5537.0025.6414.8414.0612.3315.909.5313.2111.5011.858.2510.489.028.736.687.166.085.335.826.385.062.582.16NANA
Accounts Payable Current 2.875.8910.604.079.4610.045.304.836.834.0713.4212.207.654.634.063.942.812.171.815.714.083.232.603.7012.235.957.545.295.034.864.945.992.582.162.510.591.201.060.870.810.880.990.800.710.580.50NANA
Accrued Liabilities Current 46.8632.5023.7118.5214.0029.5212.869.575.399.414.423.996.505.175.723.915.042.164.133.484.561.992.184.764.596.263.833.925.381.732.041.151.401.070.910.680.640.710.820.840.731.022.382.390.860.47NANA
Contract With Customer Liability Current 74.1084.2997.87108.65111.06150.93144.886.7419.2926.2733.1754.0377.7775.6890.89124.930.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31
Liabilities Noncurrent 134.75149.39112.45128.95154.79102.60144.0619.6820.0420.3614.1814.388.7424.0731.4934.844.004.024.164.304.455.225.9810.057.5111.276.626.686.754.914.974.934.982.562.622.762.871.501.491.552.392.222.142.250.74NANANA
Minority Interest 19.8220.25NANANANANANANA-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-1.86-1.82-1.76-1.65-1.55-1.37-1.20-0.92-0.67-0.42-0.23-0.06NANA
Operating Lease Liability Noncurrent 78.8078.2322.7022.4923.3022.8522.5319.6820.04NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31
Stockholders Equity 398.52453.93NANA408.82NANANA461.78493.14494.12500.08244.59226.23201.20172.0695.80102.31114.2770.7581.4290.1093.8997.7695.5859.9874.4892.92110.18131.30144.75146.26166.54186.36191.4082.7327.5034.965.318.9710.019.3712.2416.1712.7910.63NANA
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 418.34474.18452.27372.56408.82436.89445.55454.47461.78492.59493.56499.53244.04225.67200.64171.5095.24101.76113.7270.2080.8789.5493.3497.2195.0259.4373.9392.37109.62130.74144.20145.71165.99185.81189.5480.9125.7333.313.767.608.818.4511.5715.7512.5610.57NANA
Common Stock Value 0.200.200.200.200.200.200.200.200.190.190.190.190.190.190.190.180.180.180.180.170.170.170.170.170.160.150.150.150.150.150.150.150.150.150.140.130.120.120.110.110.110.110.110.110.090.07NANA
Additional Paid In Capital Common Stock 1219.211189.111115.371080.041053.391017.95996.64978.65965.41948.53936.35922.05664.09657.14652.41NA582.90NANANANANANANANANANANANANANANA391.16388.56381.97259.37193.51187.28151.57149.98145.92139.94136.49136.32127.48121.65NANA
Retained Earnings Accumulated Deficit -820.75-735.24-663.20-707.56-644.69-581.32-551.39-524.58-503.84-455.41-441.80-421.96-419.29-431.00-451.33-475.23-487.27-476.50-460.90-446.01-432.82-422.08-416.56-410.52-398.44-376.21-356.79-335.98-316.71-291.97-276.03-247.35-224.77-202.34-190.71-176.77-166.14-152.45-146.37-139.61-135.00-129.68-121.69-116.36-113.87-111.10NANA
Accumulated Other Comprehensive Income Loss Net Of Tax -0.14-0.14-0.11-0.11-0.070.060.100.200.02-0.18-0.63-0.20-0.39-0.10-0.07-0.04-0.02-0.000.030.020.03-0.02-0.03-0.190.01-0.030.06-0.09-0.14NANANANANANANANANANANANANANANANANANANA
Minority Interest 19.8220.25NANANANANANANA-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-0.56-1.86-1.82-1.76-1.65-1.55-1.37-1.20-0.92-0.67-0.42-0.23-0.06NANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 29.2033.3933.8024.5034.6218.5515.368.1415.8710.0512.974.495.121.962.602.722.642.271.462.092.011.711.742.424.052.752.422.383.532.492.212.011.942.041.200.520.420.360.360.400.400.420.170.250.30NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31
Net Cash Provided By Used In Operating Activities -68.67-68.8562.73-61.35-24.12-29.61263.87-38.92-10.85-33.43-27.58-23.5313.8110.53-19.59168.28-2.68-14.41-15.44-14.69-9.20NANANANANANANANANANANANANANANANANANANANANANANANANANANA
Net Cash Provided By Used In Investing Activities 36.4561.28-69.75-33.38-118.25-19.54-34.0530.16-65.89-6.03-178.139.2816.8314.40-11.22-67.763.25-28.8516.821.36-4.22NANANANANANANANANANANANANANANANANANANANANANANANANANANA
Net Cash Provided By Used In Financing Activities 0.8560.601.851.890.812.752.635.101.002.131.33253.481.832.772.6759.111.571.4556.900.03-0.12NANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31
Net Cash Provided By Used In Operating Activities -68.67-68.8562.73-61.35-24.12-29.61263.87-38.92-10.85-33.43-27.58-23.5313.8110.53-19.59168.28-2.68-14.41-15.44-14.69-9.20NANANANANANANANANANANANANANANANANANANANANANANANANANANA
Net Income Loss -85.51-72.0544.37-62.87-63.37-29.92-26.82-20.73-48.43-13.61-19.84-2.6711.7020.3423.9012.04-10.76-15.61-14.88-13.20-10.73-5.52-6.04-12.09-22.22-19.42-20.82-19.26-24.75-15.94-28.68-22.58-22.43-11.63-13.94-10.63-13.69-6.08-6.76-4.61-5.31-7.99-5.34-2.49-2.78-1.822.91-1.44
Profit Loss NANA44.37-62.87-63.37-29.92-26.82-20.73-48.43-13.61-19.84-2.6711.7020.3423.9012.04-10.76-15.61-14.88-13.20-10.73-5.52-6.04-12.09-22.22-19.42-20.82-19.26-24.75-15.94-28.68-22.58-22.43-11.63-13.98-10.69-13.81-6.18-6.94-4.78-5.60-8.24-5.58-2.69-2.95-2.012.70-1.23
Depreciation Depletion And Amortization 2.202.202.202.102.101.601.501.401.351.110.950.830.660.580.750.75NANANANANANANANANANANANANANANANA0.270.280.400.400.400.450.450.450.450.420.420.450.060.070.070.07
Increase Decrease In Accounts Receivable 1.17-1.081.17-10.119.58-0.28-8.058.16-20.8520.43-0.080.68-1.38-11.3810.252.840.31-0.00-0.130.08-0.870.360.52-0.01NANA-1.031.05NANANANANANANANANANANANANANANANANANANANA
Increase Decrease In Accounts Payable -3.03-4.716.54-5.39-0.584.740.47-2.002.76-9.341.224.553.020.570.131.130.640.36-3.901.630.840.64-0.34-4.651.64-1.602.250.260.17-0.07-1.013.420.42-0.321.92-0.610.140.190.06-0.07-0.120.180.090.140.080.25-2.021.85
Share Based Compensation 29.2033.3933.8024.5034.6218.5515.368.1415.8710.0512.974.495.121.962.602.722.642.271.462.092.011.711.742.424.052.752.422.383.532.492.212.011.942.041.200.520.420.360.360.400.400.420.170.250.300.350.360.37

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31
Net Cash Provided By Used In Investing Activities 36.4561.28-69.75-33.38-118.25-19.54-34.0530.16-65.89-6.03-178.139.2816.8314.40-11.22-67.763.25-28.8516.821.36-4.22NANANANANANANANANANANANANANANANANANANANANANANANANANANA
Payments To Acquire Property Plant And Equipment 32.719.544.755.788.203.937.174.271.882.143.614.327.833.220.210.740.710.200.380.140.111.161.365.302.710.650.090.410.830.280.300.550.470.640.490.120.110.160.020.010.090.120.210.070.000.00NANA
Payments To Acquire Investments 0.0075.0082.5265.88145.5155.20NANA85.0013.44NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31
Net Cash Provided By Used In Financing Activities 0.8560.601.851.890.812.752.635.101.002.131.33253.481.832.772.6759.111.571.4556.900.03-0.12NANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31
Revenues 31.5732.41151.8127.4438.2845.8932.8121.307.6327.3823.5329.4543.2942.7048.1534.6611.260.730.653.518.719.348.994.370.030.040.040.040.040.120.040.170.040.040.040.040.040.040.040.160.040.050.030.020.000.000.000.30
Revenue From Contract With Customer Excluding Assessed Tax 31.5732.41151.8127.4438.2845.8932.8121.307.6327.3823.5329.4543.2942.7048.1534.6611.260.730.653.518.719.348.994.370.030.040.040.040.040.120.040.170.040.040.040.040.040.040.040.160.040.050.030.020.000.000.000.30
Amgen Incorporated, Olpasiran And A R O A M G1 Agreement NA0.000.000.000.000.000.000.000.1020.000.000.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Glaxosmithkline Intellectual Property Limited, A R O H S D Agreement NA0.00120.00NANA0.000.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Horizon Therapeutics Ireland D A C, A R O X D H Agreement 6.706.706.706.706.700.000.000.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Horizon Therapeutics Ireland D A C, A R O X D H Supply Agreement 1.200.001.30NANA0.000.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Janssen Pharmaceuticals Incorporation, J N J3989 A R O H B V Agreement NA0.000.000.000.000.007.5012.707.106.9022.2028.8042.7042.3047.90NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Janssen Pharmaceuticals Incorporation,JNJ75220795AROJNJ1 3.300.000.100.000.000.200.100.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Takeda Pharmaceuticals United States Of America Incorporated, License And Co Funding Agreement 18.7025.5020.8020.8021.5035.7025.408.200.000.000.000.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Net Income Loss
Expenses
Other Nonoperating Income Expense
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Operating Lease Right Of Use Asset
Current Assets
Marketable Securities Current
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Operating Lease Liability
Current Liabilities
Operating Lease Liability Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Investments
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Other Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
dei:LegalEntity, us-gaap:TypeOfArrangement
('arwr:JanssenPharmaceuticalsIncorporation', None)
Revenue From Contract With Customer Excluding Assessed Taxdei: Legal Entity, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
dei:LegalEntity, us-gaap:TypeOfArrangement
('arwr:HorizonTherapeuticsIrelandDAC', None)
Revenue From Contract With Customer Excluding Assessed Taxdei: Legal Entity, us-gaap: Type Of Arrangement
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType
(None,)
Allocated Share Based Compensation Expenseus-gaap: Award Type
us-gaap:ContractWithCustomerLiabilityCurrent
dei:LegalEntity, us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement
('arwr:TakedaPharmaceuticalsUnitedStatesOfAmericaIncorporated', None, 'arwr:LicenseAndCoFundingAgreement')
Contract With Customer Liability Currentdei: Legal Entity, us-gaap: Balance Sheet Location, us-gaap: Type Of Arrangement
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents
(None,)
Stockholders Equity Including Portion Attributable To Noncontrolling Interestus-gaap: Statement Equity Components
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
dei:LegalEntity, us-gaap:TypeOfArrangement
('arwr:JanssenPharmaceuticalsIncorporation', None)
Revenue From Contract With Customer Excluding Assessed Taxdei: Legal Entity, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
dei:LegalEntity, us-gaap:TypeOfArrangement
('arwr:HorizonTherapeuticsIrelandDAC', None)
Revenue From Contract With Customer Excluding Assessed Taxdei: Legal Entity, us-gaap: Type Of Arrangement